showed a trendp = 0.083
Tumor samples with Periostin high FAP low PDGFR low SMA high just showed a trend for a worse overall survival ( n (low) = 15, n (high) = 16, p = 0.083, Figure 2 B).
Tumor samples with Periostin high FAP low PDGFR low SMA high just showed a trend for a worse overall survival ( n (low) = 15, n (high) = 16, p = 0.083, Figure 2 B).
Although the T4a group showed a trend towards lower recurrence rates compared to the T4b group (18.3% vs. 31.4%, P = 0.083), the 3-year OS (81.6% vs. 72.0%, P = 0.596) and DFS (74.4% vs. 55.3%, P = 0.228) were numerically higher in the T4a cohort, though none of these differences reached statistical significance (Table 6 , Fig. 3 ).
1 ). When we used the subranks, the Cochran- Q tests revealed a similar pattern to the one seen in the case of holistic rank (Table 1 ): Formally dominant dogs’ success rate only improved after owner demonstration (Trial 1–2 : Z = − 1.73, p = 0.083; Trial 1–3 : Z = − 2, p = 0.046), while subordinates only showed a trend-like improvement in the dog demonstration group (Trial 1–2 : Z = − 1.73, p = 0.083; Trial 1–3 : Z = − 1.73, p = 0.083, Fig. 2 a).
For the ANOVA analysis was only slightly not significant, the Tukey test was conducted and showed a trend for a more frequent inability to taper glucocorticoids ( p = 0.083 vs moderate disease activity; p = 0.093 vs CRP).
However, surgery showed a trend to having a higher proportion of ≥ 50% volume reduction in microcystic lesions (82% vs 68%, p = 0.083), while sclerotherapy was more effective in mixed lesions (80% vs 72%, p = 0.120).
There were no significant differences in VAS scores between the groups of patients with each stabilizer, although the group of patients with the DIAM system in place showed a trend ( p = 0.083) toward better results than the group of patients with the Wallis system in place.
HOMA-IR showed a trend towards a higher value in the group with complication, which did not reach statistical significance ( p = 0.083).
Contrarily, in tPDPNs high subgroup, receiving ACT just showed a trend toward OS improvement, while could not predict DFS benefits ( P = .083 and P = .536; Figure 3c ).
No significant associations were observed for the Married or Separated/Single groups, although the latter showed a trend toward better performance (RR = 0.86; 95% CI: 0.72 to 1.00, p = 0.083).
Univariate analysis showed a trend toward reduced VTE risk with reduced LMWH prophylaxis (OR = 0.31, 95% CI: 0.08–1.16, P = 0.083), which remained non-significant after multivariate adjustment for ALBI score, PT, cirrhosis, major hepatectomy, and other covariates (adjusted OR = 0.33, 95% CI: 0.09–1.21, P = 0.098).
While cTnT at POST +4 did not reveal any correlation, CK-MB at POST +4 showed a trend (r = 0.498, p = 0.083) and CK a moderate association with BMI-normalized LVEDD at BL (r = 0.634, p = 0.020).
These analyses revealed that participants with higher PPVT scores (thus, bigger vocabulary size) were in general good at learning novel words (association test accuracy; F(1,43) = 4.48, p = .040, η p 2 = .094), and showed a trend for better free recall on Day8 compared to Day1 ( F(1,41) = 3.16 , p = .083, η p 2 = .072).
Additionally, sVCAM-1 showed a trend towards reduced cachexia risk ( p = 0.083).
Early CA-AKI risk within 24 hours was notably influenced by clopidogrel (p<0.05), while ARBs showed a trend towards increased risk (p=0.083) and ticagrelor showed potential protection (p=0.076).
Regarding cartilage volume, LDL showed a trend toward negative association with total cartilage volume (β = −0.197, P = 0.083), while lean mass was strongly positively associated with total cartilage volume (β = 0.092, 95% CI: 0.072 to 0.113, P < 0.001).
The factors associated with the occurrence of complications were further evaluated, and performance index ( p = 0.035), and blood loss/body weight ( p < 0.0001) were strongly correlated with the result, and operation time also showed a trend in the occurrence of the complication ( p = 0.083) ( Table 4 ).
However, MS patients showed a trend towards a negative linear relationship between the p-MFIS and the average V–V FC of the cervical spinal cord ( B = −27.380, P = 0.083, R 2 = 0.720).
sNfL levels showed a trend towards correlation with duration of hypotensive episodes (MAP drops < 60 mmHg) ( r 2 = 0.20, p = 0.083).
Participants with false‐negative results showed a trend toward lower CD4 nadir counts compared with true negatives (median 102 [IQR, 51–290] vs. 268 [139–394] cells/μL, p = .083), and they had a significantly higher number of HPV genotypes (median, 5.0 [IQR, 5.0–9.0] vs. 3.0 [IQR, 1.0–5.0], p = .002) (Table S1 , Supporting Information).
perfringens strains was positively correlated with the in vitro NetB titre (Pearson r = 0.92; p = 0.028) but showed a trend towards a negative correlation with the in vitro alpha toxin production (Spearman r = −0.90; p = 0.083) ( Figure 6 ).
The results showed a trend for a difference ( Z = −1.731, p = 0.083, Cohen's d = 0.504) in the SSRT between the HTA (316.75 ± 32.94 ms) and LTA (299.78 ± 34.45 ms) groups.
The Overall Survival Analysis of Candidate Biomarkers in Sera of CCA Patients The overall survival (OS) analysis by the Kaplan–Meier method with a log rank test revealed that only CCA patients with a high level of angiopoietin-2 showed a trend of shorter survival times than those with a low angiopoietin-2 level ( p = 0.083).
Also, high EphA5 expression showed a trend of correlation with higher probability of longer disease-free survival ( Figure 2 , p = 0.083).
As might be expected, patients with the most prolonged ocSSRT in the OFF phase showed a trend for the greatest improvements from OFF to ON, although this just failed to reach significance (correlation coefficient between OFF ocSSRT and change in ocSSRT was 0.378, p = 0.083).By contrast, there was no relationship between the OFF RT and the change in ocSSRT from OFF to ON (correlation coefficient 0.117, p = 0.61).
In addition, newborns treated with propranolol showed a trend toward a reduced progression to stage 2 (RR 0.855, 95% CI 0.715-1.021; p = 0.083) and to stage 3 without plus (RR 0.724, 95% CI 0.491-1.069; p = 0.104).